News & Updates

MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.

This technology for storing and transmitting quantum information over lossy links could provide the foundation for scalable quantum networking.

The advance brings quantum error correction a step closer to reality.

A visionary entrepreneur and innovator, Yoon, who serves as president and chief strategic officer of NCSOFT, an MIT.nano founding member company, will focus on entrepreneurship, supporting female engineers, and fostering inclusive innovation.

Read more at MIT News.

Professor and two additional MIT affiliates honored for influential work on optical coherence tomography, which allows rapid detection of retinal disease, among other applications.

Researchers can use the model to predict how engineered forms of insulin would perform in human patients, making it easier to bring these drugs to clinical trials.

Inventions in medical imaging, aircrew scheduling, data security, and quantum networking are named among the year’s most innovative new products.

The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.

Brad Pentelute and his lab compel the anthrax delivery system to deliver antibody and peptide variants into cells to treat cancer.